One-Year Outcome of Patients With Atrial Fibrillation Undergoing Coronary Artery Stenting: An Analysis of the AFCAS Registry-Reference-Cited by-同舟云学术

One-Year Outcome of Patients With Atrial Fibrillation Undergoing Coronary Artery Stenting: An Analysis of the AFCAS Registry

Published:2014-01-30 Issue:6 Volume:37 Page:357-364
ISSN:0160-9289
Container-title:Clinical Cardiology
language:en
Short-container-title:Clin Cardiol

Author:

Rubboli Andrea¹,Schlitt Axel²³,Kiviniemi Tuomas⁴,Biancari Fausto⁵,Karjalainen Pasi P.⁶,Valencia Josè⁷,Laine Mika⁸,Kirchhof Paulus⁹,Niemelä Matti¹⁰,Vikman Saila¹¹,Lip Gregory Y. H.⁹,Airaksinen K. E. Juhani⁴,

Affiliation:

1. Division of Cardiology; Laboratory of Interventional Cardiology; Ospedale Maggiore Bologna Italy

2. Department of Medicine III; Martin Luther-University; Halle Germany

3. Department of Cardiology; Paracelsus Harz-Clinic; Bad Suderode Germany

4. Heart Center; Turku University Hospital and University of Turku; Turku Finland

5. Department of Surgery; University Hospital; Oulu Finland

6. Heart Center; Satakunta Central Hospital; Pori Finland

7. Department of Cardiology; University Hospital; Alicante Spain

8. Department of Medicine; Division of Cardiology, University Hospital; Helsinki Finland

9. University of Birmingham Centre for Cardiovascular Sciences; City Hospital; Birmingham United Kingdom

10. Division of Cardiology; University Hospital; Oulu Finland

11. Heart Center; University Hospital; Tampere Finland

Funder

Novartis-Germany

Publisher

Wiley

Subject

Cardiology and Cardiovascular Medicine,General Medicine

Reference18 articles.

1. Management of antithrombotic therapy in atrial fibrillation patients presenting with acute coronary syndrome and/or undergoing percutaneous coronary intervention/stenting;Lip;Thromb Haemost,2010

2. Consensus document: antithrombotic therapy in patients with atrial fibrillation undergoing coronary stenting. A North American perspective;Faxon;Thromb Haemost,2011

3. Guidelines for the management of atrial fibrillation: the Task Force for the Management of Atrial Fibrillation of the European Society of Cardiology (ESC);Camm;Eur Heart J.,2010

4. Risk of bleeding in patients with acute myocardial infarction treated with different combinations of aspirin, clopidogrel, vitamin K antagonists in Denmark: a retrospective analysis of nationwide registry data;Sørensen;Lancet.,2009

5. Risk of bleeding with single, dual, or triple therapy with warfarin, aspirin, and clopidogrel in patients with atrial fibrillation;Hansen;Ann Intern Med.,2010

Cited by 88 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Antithrombotic therapies in Canadian atrial fibrillation patients with concomitant coronary artery disease: Insights from the CONNECT AF + PCI-II program;Journal of Cardiology;2023-08

2. Design of the PERSEO Registry on the management of patients treated with oral anticoagulants and coronary stent;Journal of Cardiovascular Medicine;2022-09-07

3. Dual versus triple antithrombotic therapy after percutaneous coronary intervention: the prospective multicentre WOEST 2 Study;EuroIntervention;2022-07

4. Triple Antiplatelet Therapy and Combinations with Oral Anticoagulants after Percutaneous Coronary Intervention;Interventional Cardiology;2022-05-06

5. ANMCO position paper on antithrombotic treatment of patients with atrial fibrillation undergoing intracoronary stenting and/or acute coronary syndromes;European Heart Journal Supplements;2022-05-01